Rob Bancroft | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,384 results for “Rob Bancroft”

Trials

View all 734 →

The ROB-OSTIAL Study

1 participants · First posted Dec 2, 2022

Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate

224 participants · First posted Sep 5, 2007

Robustness Predictive Factors in People Aged Over 75 Years After Going to the Emergency Room (ROB-U)

110 participants · First posted Dec 24, 2020

Drugs

View all 460 →

Rob-895

Investigational

Rabeximod

C₂₂H₂₄ClN₅O

XOB

Organizations

Rox Medical, Inc.

United States

Robb, Geoffrey L

United States

ROC Opco LLC

United States

News

View all 186 →

AEON Biopharma Appoints Rob Bancroft as New CEO to Lead ABP-450 Therapeutic Development

AEON Biopharma Secures $22 Million Funding to Advance BOTOX Biosimilar ABP-450 Development

AEON Biopharma Achieves 100% Amino Acid Sequence Match with BOTOX in Biosimilar Development

Page 1 of 139